PharmaShots | Incisive News in 3 Shots

Subscribe Now

RadioMedix

RadioMedix and Orano Med’s AlphaMedix Receives the US FDA’s Breakthrough Therapy Designation for Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

RadioMedix and Orano Med’s AlphaMedix Receives the US FDA’s Breakthrough Therapy Designation for Gastroenteropancreatic Neuroendoc...

February 13, 2024

Insights+: The US FDA New Drug Approvals in September 2020

Insights+: The US FDA New Drug Approvals in September 2020

October 15, 2020

RadioMedix and Curium Detectnet (copper Cu 64 dotatate injection) Receives US FDA's Approval for Positive Neuroendocrine Tumors (NETs)

RadioMedix and Curium Detectnet (copper Cu 64 dotatate injection) Receives US FDA's Approval for Positive Neuroendocrine Tumors (N...

September 3, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us